Array CEO: Partnerships Smart While Cancer Drug Develops

Now watching

Next video starts in : 7 Play

Array CEO: Partnerships Smart While Cancer Drug Develops

Array CEO: Partnerships Smart While Cancer Drug Develops
Replay video
Up next

Stocks stumble as traders seek safety

Unlock your personal NFL Now stream by signing in to NFL.com

Array CEO: Partnerships Smart While Cancer Drug Develops

by TheStreet.com Videos 2:52 mins

Array BioPharma will soon be entering a pivotal trial for its wholly owned blood cancer drug and investors should know its outlook by the end of 2014, says the company's CEO Ron Squarer. Array is also partnering with AstraZeneca and Novartis on a number of other cancer drugs with trials soon getting underway that could transform the company by year end. Squarer says Array is superior at smaller, faster hematology studies, while partnerships work better for larger projects, and he is not giving away the store when teaming up with the likes of Celgene.

View Comments (0)